Evidence map›Paper›PMID 31167904›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2019

Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection.

Q R Ducarmon, R D Zwittink, B V H Hornung, W van Schaik, V B Young, E J Kuijper

Abstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 315 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
315citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

315 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Tannic acid as a multi-target regulator of intestinal barrier function in livestock.Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Gut microbiota in health and disease.Molecular biomedicine · 2026
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

255 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Q R DucarmonCenter for Microbiome Analyses and Therapeutics, Leiden University Medical Center, Leiden, Netherlands q.r.ducarmon@lumc.nl.
R D ZwittinkCenter for Microbiome Analyses and Therapeutics, Leiden University Medical Center, Leiden, Netherlands.
B V H HornungCenter for Microbiome Analyses and Therapeutics, Leiden University Medical Center, Leiden, Netherlands.
W van SchaikInstitute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
V B YoungDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0003-3687-2364
E J KuijperCenter for Microbiome Analyses and Therapeutics, Leiden University Medical Center, Leiden, Netherlands.

Funding

Systems biology of Clostridium difficile infectionU01AI124255 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHLOSS, PATRICK DAVID, YOUNG, VINCENT B · 2016 to 2020
$9.8M
Diversity and stability relationships in the murine microbiomeR01GM099514 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHLOSS, PATRICK DAVID · 2012 to 2015
$1.4M
Development of reproducible informatics skills among microbiome researchersR25GM116149 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHLOSS, PATRICK DAVID · 2015 to 2016
$148k
NCEZID CDC HHS U54 CK000481NCEZID CDC HHS U54 CK000607NIAID NIH HHS U01 AI124255NIGMS NIH HHS R01 GM099514NIGMS NIH HHS R25 GM116149
6 · The paper itself

Abstract

The gut microbiome is critical in providing resistance against colonization by exogenous microorganisms. The mechanisms via which the gut microbiota provide colonization resistance (CR) have not been fully elucidated, but they include secretion of antimicrobial products, nutrient competition, support of gut barrier integrity, and bacteriophage deployment. However, bacterial enteric infections are an important cause of disease globally, indicating that microbiota-mediated CR can be disturbed and become ineffective. Changes in microbiota composition, and potential subsequent disruption of CR, can be caused by various drugs, such as antibiotics, proton pump inhibitors, antidiabetics, and antipsychotics, thereby providing opportunities for exogenous pathogens to colonize the gut and ultimately cause infection. In addition, the most prevalent bacterial enteropathogens, including

Indexed as

Gastrointestinal MicrobiomeAnimalsAnti-Infective AgentsBacteriaBacterial InfectionsFatty Acids, VolatileHumansMiceMucusAnti-Infective AgentsFatty Acids, Volatilebacterial enteric infectionbacteriocinsbacteriophagesbile acidscolonization resistanceenteric pathogensgut microbiotamicrobiomemucus layernutrient competitionshort-chain fatty acids

Identifiers

PMID31167904
PMCPMC6710460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.